Mechanisms of resistance to EGFR tyrosine kinase inhibitors gefitinib/erlotinib and to ALK inhibitor crizotinib

Autor: Tartarone, Alfredo, Lazzari, Chiara, Lerose, Rosa, Conteduca, Vincenza, Improta, Giuseppina, Zupa, Angela, Bulotta, Alessandra, Aieta, Michele, Gregorc, Vanesa
Zdroj: In Lung Cancer September 2013 81(3):328-336
Databáze: ScienceDirect